Recent Press Releases
May 7, 2008 May 1, 2008 Apr 8, 2008 Mar 3, 2008Allergan Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of BOTOX(R) for Therapeutic Uses
Feb 8, 2008Commenting on the U.S. Food and Drug Administration (FDA) Early Communication, Allergan Clarifies FDA's Inquiry Relates Primarily to High Dose Medical Uses of BOTOX(R), Rather Than BOTOX(R) Cosmetic for Aesthetic Use
Jan 30, 2008 Jan 30, 2008Allergan Canada comments on the safety profile of its BOTOX(R) (Botulinum Toxin Type A) product
Jan 25, 2008Allergan, Inc. Responds to Public Citizen's Allegation Regarding a Fatality Following BOTOX(R) Cosmetic Treatment
Jan 24, 2008Allergan, Inc. Comments on BOTOX(R) (Botulinum Toxin Type A) Safety Profile
Jan 24, 2008Allergan, Inc., the #1 Global Medical Aesthetics Company, and Clinique, the #1 Prestige Cosmetics Brand in the United States, Form Strategic Collaboration to Develop New Skin Care Line
Jan 9, 2008 Dec 6, 2007 Nov 12, 2007Allergan, Inc. and Covidien Ltd. Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System
Nov 6, 2007 Oct 31, 2007Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Oct 17, 2007 Oct 11, 2007 Sep 19, 2007Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Aug 1, 2007Allergan, Inc. (NYSE:AGN) today announced operating results for the quarter ended June 29, 2007. Allergan also announced that its Board of Directors...
Jul 9, 2007| Showing 1-20 of 209 |
| Page: 1 2 3 ... 11 |
| Next 20 |